Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target|
|Citation:||Journal of Leukocyte Biology, 2016; 100(1):27-45|
|Publisher:||Federation of American Societies for Experimental Biology|
|M. Obayed Ullah, Matthew J. Sweet, Ashley Mansell, Stuart Kellie, and Bostjan Kobe|
|Abstract:||Toll/IL-1R domain-containing adaptor-inducing IFN-β (TRIF)-dependent signaling is required for TLR-mediated production of type-I IFN and several other proinflammatory mediators. Various pathogens target the signaling molecules and transcriptional regulators acting in the TRIF pathway, thus demonstrating the importance of this pathway in host defense. Indeed, the TRIF pathway contributes to control of both viral and bacterial pathogens through promotion of inflammatory mediators and activation of antimicrobial responses. TRIF signaling also has both protective and pathologic roles in several chronic inflammatory disease conditions, as well as an essential function in wound-repair processes. Here, we review our current understanding of the regulatory mechanisms that control TRIF-dependent TLR signaling, the role of the TRIF pathway in different infectious and noninfectious pathologic states, and the potential for manipulating TRIF-dependent TLR signaling for therapeutic benefit.|
|Keywords:||Adaptor protein; innate immunity; pattern recognition receptor|
|Rights:||© 2016 Society for Leukocyte Biology|
|Appears in Collections:||Agriculture, Food and Wine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.